1-2 of 2
Robb S Friedman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma

Clinical Trials & Observations
Andrew J. Yee, Jacob P Laubach, Erica L. Campagnaro, Brea C. Lipe, Omar Nadeem, Robb S Friedman, Craig E. Cole, Elizabeth O'Donnell, Giada Bianchi, Andrew R Branagan, Robert L. Schlossman, Samantha J. Shaprio, Cynthia C. Harrington, Jill N. Burke, Marilyn T. Gammon, Kathleen J. Lively, Cassandra A. Reimonn, Danielle X. Andrade, Robert A Redd, Jens G. Lohr, Kenneth C. Anderson, Paul G. Richardson, Noopur Raje
Journal: Blood Advances
Blood Adv bloodadvances.2024014717.
https://doi.org/10.1182/bloodadvances.2024014717
Published: 2024
Includes: Supplemental data
Journal Articles

Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia

Clinical Trials & Observations
Monica Kasbekar, Valentina Nardi, Paola Dal Cin, Andrew M. Brunner, Meghan Burke, Yi-Bin Chen, Christine Connolly, Amir T. Fathi, Julia Foster, Molly Macrae, Steven L. McAfee, Kristin McGregor, Rupa Narayan, Aura Y. Ramos, Tina T. Som, Meghan Vartanian, Robb S. Friedman, Karim A. Benhadji, Gabriela S. Hobbs
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3136–3140.
https://doi.org/10.1182/bloodadvances.2020002308
Published: 2020